Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01357928 · ClinicalTrials.gov registry record
Thromboelastography (TEG) Reference Range Study
A clinical trial, sponsored by Haemonetics Corporation.
- Completed
- Registry status
- 159
- Enrollment target
NCT01357928 is a clinical trial that has completed, run by Haemonetics Corporation. The registered enrollment target is 159 participants.
The verdict
NCT01357928 has completed, sponsored by Haemonetics Corporation.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
Study Summary
As part of a system wide reagent verification plan Haemoscope Corporation will be running a study to verify the reference intervals of many of the reagents. Reference intervals will be constructed following the guidelines set out in CLSI document C28-A3c. This guideline calls for a reference interval to be constructed from at least 120 donors. Some reagents currently have ranges in place based on fewer donors than that stated in the guideline. This procedure will provide additional testing results to meet the requirements outlined in the CLSI guideline. Reagents that currently have no reference intervals will be tested and will include a minimum of 146 donors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01357928
The ClinicalTrials.gov registry entry for NCT01357928 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Haemonetics Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01357928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01357928 about?
NCT01357928 is a clinical study titled "Thromboelastography (TEG) Reference Range Study". As part of a system wide reagent verification plan Haemoscope Corporation will be running a study to verify the reference intervals of many of the reagents. Reference intervals will be constructed following the guidelines set out in CLSI document C28-A3c. This guideline calls for a reference interva...
What is the current status of trial NCT01357928?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2011-04. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01357928?
This trial is sponsored by Haemonetics Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.